Scientists have found that creatine, a supplement widely used for muscle enhancement, increases brain energy levels and reduces early Alzheimer's cognitive decline by 30%, according to thesciverse.org. This discovery highlights a potential new avenue for managing Alzheimer's disease through a commonly available supplement.
The research involved monitoring brain energy metabolism in individuals taking creatine supplements. The study measured cognitive performance over time, comparing those using creatine with control groups. The findings showed that creatine supplementation led to a significant improvement in brain energy availability, which correlated with a slower rate of cognitive decline in early-stage Alzheimer's patients, as reported by thesciverse.org.
This finding is significant because Alzheimer's disease currently lacks effective treatments that can halt or reverse cognitive decline. Creatine's established safety profile and widespread use for muscle health make it a promising candidate for repurposing in neurodegenerative disease management. The 30% reduction in cognitive decline offers a measurable impact that could influence future therapeutic strategies and clinical guidelines, according to thesciverse.org.
The research team plans to conduct larger clinical trials to confirm these results and explore optimal dosing regimens. The next phase of the study is expected to begin later this year, aiming to provide more definitive evidence on creatine’s role in Alzheimer's treatment, thesciverse.org reported.